SRL
INMB icon

Scientech Research LLC’s INmune Bio INMB Stock Holding History

Scientech Research LLC’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
+10,483
New +$14.5K 0.01% 215
2025
Q3 		– Sell
-45,737
Closed -$106K – 705
2025
Q2 		$106K Buy
+45,737
New +$336K 0.03% 539

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Scientech Research LLC's INMB Position: Q2 2026 in Review

Scientech Research LLC opened a new position in INmune Bio (INMB) in Q2 2026: 10,483 shares worth $17.1K. The stake represents 0.01% of the portfolio and ranks #215 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in INMB as recently as Q2 2025.

Scientech Research LLC first reported a position in INMB in Q2 2025 and has held it in 2 quarters since. The position peaked at $106K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Scientech Research LLC held 10,483 shares of INmune Bio worth $17.1K as of Q2 2026.
  • INmune Bio was a new Scientech Research LLC position in Q2 2026.
  • INmune Bio made up 0.01% of Scientech Research LLC's portfolio in Q2 2026, its #215 holding.
  • Scientech Research LLC first reported a position in INmune Bio in Q2 2025 and has held it in 2 quarters since.
  • Scientech Research LLC's INmune Bio position peaked at $106K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.